Friday, August 17, 2018

New cancer clinical trial: MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer

Published on: August 16, 2018 at 12:00PM
Conditions:   Human Papillomavirus-Related Carcinoma;   Human Papillomavirus-Related Cervical Carcinoma;   Stage IB2 Cervical Cancer AJCC v8;   Stage II Cervical Cancer AJCC v8;   Stage II Vaginal Cancer AJCC v8;   Stage IIA Cervical Cancer AJCC v8;   Stage IIA Vaginal Cancer AJCC v8;   Stage IIA1 Cervical Cancer AJCC v8;   Stage IIA2 Cervical Cancer AJCC v8;   Stage IIB Cervical Cancer AJCC v8;   Stage IIB Vaginal Cancer AJCC v8;   Stage III Cervical Cancer AJCC v8;   Stage III Vaginal Cancer AJCC v8;   Stage IIIA Cervical Cancer AJCC v8;   Stage IIIB Cervical Cancer AJCC v8;   Stage IVA Cervical Cancer AJCC v8;   Stage IVA Vaginal Cancer AJCC v8
Interventions:   Radiation: Internal Radiation Therapy;   Procedure: Magnetic Resonance Imaging
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
Not yet recruiting
https://ift.tt/2L06I4x

No comments:

Post a Comment